EUVIMEDEUVIMED entdecken
Crossref

Assessment of a Novel Tool for the Clinical Grading of Nasal Septal Perforation

Amar Miglani, India Rangel iD, Cody Smith iD, Stephen F Bansberg, Devyani Lal iD, Michael J Marino iD

The Laryngoscope · 2024-07 · 134 (7) · 3049-3053

DOI: 10.1002/lary.31286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 18.01.2024. Verfasst von Amar Miglani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology - Head and Neck Surgery, Mayo Clinic, Phoenix, Arizona, U.S.A. Hauptthemen laut MEDLINE: Nasal Septal Perforation, Endoscopy, Video Recording. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nasal septal perforations (NSP) can have a heterogeneous appearance on endoscopic examination with varying degrees of crusting, inflammatory change, and associated septal deviation. The clinical applicability of these findings as contributors to patient symptoms may be enhanced by use of a standardized assessment.

Methods

Video nasal endoscopy recordings were obtained from 40 patients with NSP. Five raters with varied levels of training ranging from a senior resident to an experienced septal perforation surgeon independently reviewed the videos for the following exam findings: crusting, scarring, granulation tissue, septal deviation, and edema. Scoring for each item was reported on a 3‐point (0–2) scale, and each reviewer repeated scoring at a 14‐day interval. Interrater and intrarater agreement were calculated using Fleiss kappa for each item and the total scores. Additionally, endoscopy scores were correlated with patient‐reported NOSE‐Perf symptom scores.

Results

Interrater agreement for the overall instrument was in the “fair‐to‐moderate” range with the following interrater agreement for each item: crusting (0.458–0.575), scarring (0.286–0.308), granulation (0.403–0.406), deviation (0.487–0.494), and edema (0.253–0.406). Intrarater agreement was generally “substantial” for individual items as well as the overall instrument (0.688). The NSP endoscopy scores were moderately correlated with NOSE‐Perf scores ( r = 0.44, p = 0.008).

Conclusions

An endoscopic evaluation of NSP comprising five exam findings has acceptable interrater and intrarater reliability and correlates with patient‐reported outcomes. NSP endoscopy may be applied to future clinical studies for characterization of NSP and assessment of treatment outcomes. Level of Evidence 3 Laryngoscope , 134:3049–3053, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasal Septal PerforationEndoscopyVideo RecordingHumansFemaleMaleMiddle AgedAdultObserver VariationReproducibility of ResultsAgedNasal SeptumSeverity of Illness Index

Stichwörter der Autor:innen

edemainflammationnasal endoscopynasal septal perforationobjective assessment

Autor:innen und Institutionen

  • Department of Otorhinolaryngology - Head and Neck Surgery, Mayo Clinic, Phoenix, Arizona, U.S.A.
  • Mayo Clinic Alix School of Medicine, Scottsdale, Arizona, U.S.A.

ORCID-Profile: India Rangel, Cody Smith, Devyani Lal, Michael J Marino

Zitieren

APA

Miglani, A., Rangel, I., Smith, C., Bansberg, S. F., Lal, D., & Marino, M. J. (2024). Assessment of a Novel Tool for the Clinical Grading of Nasal Septal Perforation. The Laryngoscope, 134(7), 3049-3053. https://doi.org/10.1002/lary.31286

Vancouver

Miglani A, Rangel I, Smith C, Bansberg SF, Lal D, Marino MJ. Assessment of a Novel Tool for the Clinical Grading of Nasal Septal Perforation. The Laryngoscope. 2024;134(7):3049-3053. doi:10.1002/lary.31286

BibTeX
@article{Miglani2024,
  author = {Miglani, Amar and Rangel, India and Smith, Cody and Bansberg, Stephen F and Lal, Devyani and Marino, Michael J},
  title = {Assessment of a Novel Tool for the Clinical Grading of Nasal Septal Perforation},
  journal = {The Laryngoscope},
  year = {2024},
  volume = {134},
  number = {7},
  pages = {3049--3053},
  doi = {10.1002/lary.31286}
}
Kostenlos starten →